These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5666934)

  • 1. Hyperkalemic changes during spironolactone therapy for cirrhosis and ascites, with special reference to hyperkalemic intermittent paralysis.
    Radó JP; Marosi J; Szende L; Takó J
    J Am Geriatr Soc; 1968 Aug; 16(8):874-86. PubMed ID: 5666934
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
    Radó JP; Marosi J; Takó J; Dévényi I
    Am Heart J; 1968 Sep; 76(3):393-8. PubMed ID: 4951338
    [No Abstract]   [Full Text] [Related]  

  • 3. Iatrogenic hyperkalemic paralysis with electrocardiographic changes.
    Kalbian VV
    South Med J; 1974 Mar; 67(3):342-5. PubMed ID: 4814187
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the new diuretic: Amiloride (MK-870)].
    Jenny M
    Praxis; 1969 Sep; 58(38):1192-6. PubMed ID: 5395178
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spironolactone-induced hyperkalemic paralysis in a patient with normal liver and kidney function].
    Palmér M; Wikström B
    Lakartidningen; 1985 Dec; 82(51):4522-3. PubMed ID: 4087983
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z; Mumtaz K; Salam A; Jafri W
    J Coll Physicians Surg Pak; 2003 Jul; 13(7):382-4. PubMed ID: 12887837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone diuresis in patients with cirrhosis and ascites.
    Eggert RC
    Br Med J; 1970 Nov; 4(5732):401-3. PubMed ID: 5481518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic drug therapy of edema.
    Perez-Stable EC; Materson BJ
    Med Clin North Am; 1971 Mar; 55(2):359-72. PubMed ID: 4926056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incidence of hyperkalemia caused by Aldactone therapy and its significance in decompensated liver cirrhosis].
    Radó J; Marosi J; Takó J
    Orv Hetil; 1968 Sep; 109(35):1911-4. PubMed ID: 5714832
    [No Abstract]   [Full Text] [Related]  

  • 11. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 12. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the amount of edema in patients affect the magnitude of response to a dose of a diuretic acting on the renal tubules?
    Gold H; Messeloff CR; Mehta D; Kwit NT; Golfinos AJ; Zahm WN; Goessel E; Morris A
    J Clin Pharmacol J New Drugs; 1969; 9(6):374-83. PubMed ID: 5260200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aldacton causing intermittent hyperkalemic muscle paralysis].
    Radó J; Marosi J; Takó J; Dévényi I
    Orv Hetil; 1968 Mar; 109(9):452-5. PubMed ID: 5700012
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
    Knauf H; Wenk E; Schölmerich J; Goerg KJ; Gerok W; Leser HG; Mutschler E
    Klin Wochenschr; 1990 Jun; 68(11):545-51. PubMed ID: 2198378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
    Senewiratne B; Sherlock S
    Lancet; 1968 Jan; 1(7534):120-2. PubMed ID: 4169604
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.